Exane Derivatives’s Norfolk Southern NSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$184K Buy
810
+52
+7% +$12.8K 0.11% 181
2022
Q1
$216K Sell
758
-197
-21% -$54.3K 0.06% 311
2021
Q4
$284K Sell
955
-356
-27% -$99.4K 0.07% 270
2021
Q3
$314K Buy
1,311
+157
+14% +$40.3K 0.08% 279
2021
Q2
$302K Buy
+1,154
New +$319K 0.07% 287
2019
Q3
Sell
-7
Closed -$1.4K 683
2019
Q2
$1.4K Sell
7
-5,913
-100% -$1.17M ﹤0.01% 539
2019
Q1
$1.11M Buy
+5,920
New +$1.02M 0.22% 100
2017
Q1
Sell
-1
Closed -$108 628
2016
Q4
$108 Sell
1
-1
-50% -$101 ﹤0.01% 539
2016
Q3
$194 Buy
2
+1
+100% +$91 ﹤0.01% 512
2016
Q2
$85 Sell
1
-23
-96% -$1.96K ﹤0.01% 474
2016
Q1
$2K Hold
24
﹤0.01% 459
2015
Q4
$2.03K Hold
24
﹤0.01% 377
2015
Q3
$1.83K Buy
+24
New +$1.95K ﹤0.01% 400

Other funds holding NSC

Exane Derivatives's NSC Position: Q2 2022 in Review

Exane Derivatives increased its Norfolk Southern (NSC) stake by 6.9% in Q2 2022, buying an estimated $12.8K and bringing the position to 810 shares worth $184K. The position accounts for 0.11% of the portfolio, ranked #181.

Exane Derivatives first reported a position in NSC in Q3 2015 and has held it in 13 quarters since. The position peaked at $1.11M in Q1 2019. 1,542 funds tracked by Wall St. Rank hold NSC as of Q2 2022.

  • Exane Derivatives held 810 shares of Norfolk Southern worth $184K as of Q2 2022.
  • Exane Derivatives bought 52 Norfolk Southern shares in Q2 2022, an estimated $12.8K.
  • Norfolk Southern made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #181 holding.
  • Exane Derivatives first reported a position in Norfolk Southern in Q3 2015 and has held it in 13 quarters since.
  • Exane Derivatives's Norfolk Southern position peaked at $1.11M in Q1 2019.
  • 1,542 funds tracked by Wall St. Rank held Norfolk Southern as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.